Literature DB >> 27840049

Temporal Trends in the Utilization of Noninvasive Diagnostic Tests for Coronary Artery Disease in Ontario Between 2008 and 2014: A Population-Based Study.

Idan Roifman1, Harindra C Wijeysundera1, Peter C Austin1, Laura C Maclagan2, Mohammad R Rezai2, Graham A Wright3, Jack V Tu4.   

Abstract

The proliferation of cardiac diagnostic tests over the past few decades has received substantial attention from policymakers. However, contemporary population-based temporal trends of the utilization of noninvasive cardiac diagnostic tests for coronary artery disease are not known. Our objective was to examine the temporal trends in the utilization of coronary computed tomography angiography (CCTA), myocardial perfusion imaging (MPI), exercise stress testing (GXT), and stress echocardiography between 2008 and 2014. We performed a population-based repeated cross-sectional study of the adult population of Ontario between January 1, 2008 and December 31, 2014. Annual utilization rates of noninvasive cardiac diagnostic tests were computed. For each cardiac testing modality, a negative binomial regression model was used to assess temporal changes in test utilization. GXT and MPI collectively accounted for 88% of all cardiac noninvasive diagnostic tests throughout our study period. Age- and sex-standardized rates of GXT declined from 26.7/1000 adult population to 21.6/1000 adult population (mean annual reduction of 3.4%; P < 0.001). MPI rates declined from 21.1/1000 adult population to 19.5/1000 adult population (mean annual reduction of 1.3%; P < 0.001). Although utilization rates for both CCTA and stress echocardiography increased over time, the combined rate of all available tests decreased from 50.8/1000 adult population to 49.1/1000 adult population (mean annual reduction of 1.1%; P < 0.001). In conclusion, utilization rates for the most prevalent noninvasive cardiac diagnostic tests-GXT and MPI-declined over our study period. Furthermore, the overall test utilization rate also declined over time. We believe our findings are encouraging from a health policy perspective. Nonetheless, rising utilization rates for CCTA and stress echocardiography will need to be monitored in the future.
Copyright © 2016 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27840049     DOI: 10.1016/j.cjca.2016.07.590

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  12 in total

Review 1.  Coronary CT Angiography Derived Fractional Flow Reserve: The Game Changer in Noninvasive Testing.

Authors:  Bjarne Linde Nørgaard; Jesper Møller Jensen; Philipp Blanke; Niels Peter Sand; Mark Rabbat; Jonathon Leipsic
Journal:  Curr Cardiol Rep       Date:  2017-09-22       Impact factor: 2.931

2.  Coronary Computed Tomography Angiography in Diagnosing Obstructive Coronary Artery Disease in Patients with Advanced Chronic Kidney Disease: A Systematic Review and Meta-Analysis.

Authors:  Xingxing S Cheng; Suman Mohanty; Valery Turner; Domenico Mastrodicasa; Simon Winther; Dominik Fleischmann; Jane C Tan; William F Fearon
Journal:  Cardiorenal Med       Date:  2020-12-15       Impact factor: 4.360

3.  Impact of the Publication of Appropriate Use Criteria on Utilization Rates of Myocardial Perfusion Imaging Studies in Ontario, Canada: A Population-Based Study.

Authors:  Idan Roifman; Peter C Austin; Feng Qiu; Harindra C Wijeysundera
Journal:  J Am Heart Assoc       Date:  2017-06-05       Impact factor: 5.501

4.  Clinical Effectiveness of Cardiac Noninvasive Diagnostic Testing in Patients Discharged From the Emergency Department for Chest Pain.

Authors:  Idan Roifman; Lu Han; Maria Koh; Harindra C Wijeysundera; Peter C Austin; Pamela S Douglas; Dennis T Ko
Journal:  J Am Heart Assoc       Date:  2019-11-05       Impact factor: 5.501

5.  Appropriate utilization of cardiac computed tomography for the assessment of stable coronary artery disease.

Authors:  Michael Hammer; Muhtashim Mian; Levi Elhadad; Mary Li; Idan Roifman
Journal:  BMC Cardiovasc Disord       Date:  2021-03-26       Impact factor: 2.298

6.  Clinical Effectiveness of Cardiac Noninvasive Diagnostic Testing in Outpatients Evaluated for Stable Coronary Artery Disease.

Authors:  Idan Roifman; Atul Sivaswamy; Anna Chu; Peter C Austin; Dennis T Ko; Pamela S Douglas; Harindra C Wijeysundera
Journal:  J Am Heart Assoc       Date:  2020-07-01       Impact factor: 5.501

7.  Comparison of Anatomic and Clinical Outcomes in Patients Undergoing Alternative Initial Noninvasive Testing Strategies for the Diagnosis of Stable Coronary Artery Disease.

Authors:  Idan Roifman; Harindra C Wijeysundera; Peter C Austin; Mohammad R Rezai; Graham A Wright; Jack V Tu
Journal:  J Am Heart Assoc       Date:  2017-07-19       Impact factor: 5.501

Review 8.  The new clinical standard of integrated quadruple stress echocardiography with ABCD protocol.

Authors:  Eugenio Picano; Quirino Ciampi; Karina Wierzbowska-Drabik; Mădălina-Loredana Urluescu; Doralisa Morrone; Clara Carpeggiani
Journal:  Cardiovasc Ultrasound       Date:  2018-10-02       Impact factor: 2.062

9.  Validation of billing code combinations to identify cardiovascular magnetic resonance imaging scans in Ontario, Canada: a retrospective cohort study.

Authors:  Idan Roifman; Feng Qiu; Kim A Connelly; Graham A Wright; Michael Farkouh; Laura Jimenez-Juan; Harindra C Wijeysundera
Journal:  BMJ Open       Date:  2018-10-08       Impact factor: 2.692

10.  Use of Cardiac Noninvasive Testing After Emergency Department Discharge: Association of Hospital Network Testing Intensity and Outcomes in Ontario, Canada.

Authors:  Idan Roifman; Lu Han; Maria Koh; Harindra C Wijeysundera; Peter C Austin; Pamela S Douglas; Dennis T Ko
Journal:  J Am Heart Assoc       Date:  2020-10-22       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.